| |
| |
|
| Insider
Information: |
Winningham Rick E |
| Relationship: |
|
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
2,686,408 |
|
|
Indirect Shares
|
96,467 |
|
|
| Direct
Value |
$32,096,465 |
|
|
|
Indirect Value
|
$926,083 |
|
|
| Total
Shares |
2,782,875 |
|
|
| Total
Value |
$33,022,548 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -15.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Innoviva Inc |
INVA |
Director |
2014-08-15 |
825,391 |
2008-01-29 |
0 |
Premium* |
|
|
Jazz Pharmaceuticals Inc |
JAZZ |
Director |
2023-08-14 |
10,444 |
2012-01-11 |
0 |
Premium* |
|
|
Theravance Biopharma, Inc. |
TBPH |
|
2024-04-02 |
1,850,573 |
2024-04-02 |
96,467 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2015-08-10 |
4 |
S |
$179.98 |
$144,178 |
D/D |
(801) |
14,659 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-10 |
4 |
S |
$176.61 |
$116,563 |
D/D |
(660) |
4,950 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-09 |
4 |
S |
$176.03 |
$2,814,838 |
D/D |
(15,979) |
5,610 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2022-08-08 |
4 |
S |
$152.32 |
$165,879 |
D/D |
(1,089) |
8,610 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2017-06-01 |
4 |
S |
$150.00 |
$750,000 |
D/D |
(5,000) |
10,391 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2021-08-06 |
4 |
S |
$147.96 |
$193,236 |
D/D |
(1,306) |
7,138 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2017-08-11 |
4 |
S |
$142.36 |
$94,248 |
D/D |
(662) |
11,094 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-04-17 |
4 |
AS |
$140.00 |
$3,850,000 |
D/D |
(27,500) |
13,587 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2023-08-14 |
4 |
S |
$138.16 |
$171,455 |
D/D |
(1,241) |
10,444 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2016-08-15 |
4 |
S |
$136.45 |
$86,373 |
D/D |
(633) |
15,391 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2019-08-09 |
4 |
S |
$135.65 |
$98,482 |
D/D |
(726) |
4,424 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2014-08-12 |
4 |
S |
$133.15 |
$144,734 |
D/D |
(1,087) |
14,150 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2020-08-07 |
4 |
S |
$125.87 |
$117,185 |
D/D |
(931) |
6,198 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2013-08-13 |
4 |
S |
$81.86 |
$87,590 |
D/D |
(1,070) |
41,087 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2012-01-11 |
4 |
D |
$48.60 |
$842,870 |
D/D |
(17,343) |
37,657 |
0 |
- |
|
| JAZZ |
Jazz Pharmaceuticals Inc |
Director |
– • – |
2018-08-09 |
4 |
OE |
$46.83 |
$578,655 |
D/D |
9,000 |
20,094 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-09-12 |
4 |
AS |
$40.03 |
$894,791 |
D/D |
(22,353) |
690,106 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2014-02-20 |
4 |
D |
$39.98 |
$371,694 |
D/D |
(9,297) |
670,763 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-05-20 |
4 |
D |
$37.01 |
$371,802 |
D/D |
(10,046) |
711,505 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2017-05-20 |
4 |
D |
$36.83 |
$569,392 |
D/D |
(15,460) |
856,377 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-11-20 |
4 |
D |
$36.40 |
$365,674 |
D/D |
(10,046) |
680,060 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-08-20 |
4 |
D |
$35.89 |
$360,551 |
D/D |
(10,046) |
712,459 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2017-02-20 |
4 |
D |
$33.78 |
$1,123,658 |
D/D |
(33,264) |
870,135 |
0 |
- |
|
| INVA |
Innoviva Inc |
Chief Executive Officer |
• • – |
2013-04-30 |
4 |
AS |
$33.64 |
$8,597,169 |
D/D |
(255,532) |
721,551 |
0 |
- |
|
| TBPH |
Theravance Biopharma, Inc... |
Chief Executive Officer |
• • – |
2016-11-20 |
4 |
D |
$31.96 |
$267,186 |
D/D |
(8,360) |
875,399 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
